Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS
Heterogeneity and Plasticity of Multiple Myeloma | IntechOpen
Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chron
-Immunocytochemistry-Immunofluorescence-NBP2-34258-img0004.jpg "Kappa Light Chain Antibody (HP6053 + L1C1) (NBP2-34258): Novus Biologicals")
Kappa Light Chain Antibody (HP6053 + L1C1) (NBP2-34258): Novus Biologicals
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
plus dead) labeled
Types of Multiple Myeloma | International Myeloma Foundation
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
2-Methoxyestradiol at low dose induces differentiation of myeloma cells
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma
miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma
Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS
Myeloma Explained | Haematology | Oncology | onthewards
The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients - Experimental Hematology
The Expression and Localization of Kappa Myeloma Antigen on Malignant and Normal B cells
Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s
miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma
A novel xenograft mouse model for testing approaches targeting human kappa light-chain diseases | Gene Therapy
Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1 | Haematologica
plus dead) labeled
Goat anti-Human Lambda Light Chain Secondary Antibody (NBP1-72788): Novus Biologicals
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma
Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS). - Abstract - Europe PMC
PDF) Illegitimate WNT signaling promotes proliferation of multiple myeloma cells
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chron
